Pharmaceutical News

RSS

Simvastatin hinders positive effects of exercise for obese adults, say researchers

Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders including excess body fat and/or high levels of blood pressure, blood sugar and/or cholesterol.

17 May 2013

RuiYi signs agreement with Genor BioPharma for development of RYI-008 in China

RuiYi Inc. announced today that it has entered into an exclusive license and collaborative development agreement with Genor BioPharma for the development of RYI-008 in China.

16 May 2013

Scientists reveal inside story of European regulatory review and approval of Glybera

The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

16 May 2013

Study underscores new paradigm in cancer therapy

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers.

16 May 2013

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

16 May 2013

Prostate cancer drug Xofigo gets FDA approval

The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs.

16 May 2013

Brazilian investigators call for targeted interventions among young crack users

A Brazilian investigative team, collaborating with a Simon Fraser University researcher, is citing an urgent need for targeted interventions among young crack users in cities throughout Brazil, identified as the world's biggest crack market, and further research to better address the problem.

15 May 2013

Magic bullet nanomedicine offers potential treatment option for Acute Lung Injury

Researchers at Queen's University Belfast have devised a 'magic bullet' nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.

15 May 2013

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.

15 May 2013

Novel drug may increase the effectiveness of radiation therapy for brain cancer

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy.

15 May 2013

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Sigma-Tau Pharmaceuticals, Inc. announced today that the Company was recognized last evening as a rare disease pioneer at the 30th anniversary celebration of The National Organization for Rare Disorders.

15 May 2013

Obama administration asks appeals court to delay judge's order on emergency contraceptive

The federal government's legal fight over the availability of emergency contraception is heating up at the next level in the courts.

15 May 2013

Subsidiary of Indian drug firm pleads guilty, agrees to $500 million penalty

A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S.

15 May 2013

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage).

15 May 2013

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

14 May 2013

CMC Biologics, RuiYi to develop a cell line for RYI-008

CMC Biologics today announced the execution of an agreement with RuiYi Inc. to develop a cell line for RYI-008, a novel anti-IL-6 monoclonal antibody.

14 May 2013

Renaissance in drug development for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.

14 May 2013

Pharmaceutical News

Simvastatin hinders positive effects of exercise for obese adults, say researchers

RuiYi signs agreement with Genor BioPharma for development of RYI-008 in China

Scientists reveal inside story of European regulatory review and approval of Glybera

Study underscores new paradigm in cancer therapy

Simponi injection gets FDA approval to treat adults with ulcerative colitis

Prostate cancer drug Xofigo gets FDA approval

Brazilian investigators call for targeted interventions among young crack users

Magic bullet nanomedicine offers potential treatment option for Acute Lung Injury

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Sigma-Tau Pharmaceuticals recognized as a rare disease pioneer

Obama administration asks appeals court to delay judge's order on emergency contraceptive

Subsidiary of Indian drug firm pleads guilty, agrees to $500 million penalty

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

CMC Biologics, RuiYi to develop a cell line for RYI-008

Renaissance in drug development for rare diseases

Neutra in final stages of negotiations toward new partnership in U.S. MMJ industry

Medicare lags in detecting hazardous prescribing patterns

Research findings may pave way to new treatment for Alzheimer's disease in humans

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News